List of publications

 

BETPSY Project

 

Biomarkers in autoimmune EncephaliTis and

Paraneoplastic neurological SYndromes

 

 

Scientific articles 

Muñiz-Castrillo S, Hedou J, and al. Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis, Brain, 2021;, awab153, https://doi.org/10.1093/brain/awab153(WP1)

Muñiz‑Castrillo S, Haesebaert J and al. Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021. DOI: https://doi.org/10.1212/NXI.0000000000000974 (WP3)

Muñiz‑Castrillo S, Vogrig A and al. Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study. Journal of neurology. 2021. https://doi.org/10.1007/s00415-021-10424-w (WP3)

Moritz C, and al. CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups. Neurol Neuroimmunol Neuroinflamm. 2021. doi.org/10.1212/NXI.0000000000000944 (WP2)

Vogrig A, and al. Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors. Neurology. 2020. doi.org/10.1212/WNL.0000000000011340 (WP1)

Moritz C and al. Proper definition of the set of autoantibody-targeted antigens relies on appropriate reference group selection. New biotechnology. 2020. doi.org/10.1016/j.nbt.2020.08.007 (WP2)

Hébert J, Riche B and al. Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France. Neurol Neuroimmunol Neuroinflamm. 2020; 7 (6). https://doi.org/10.1212/NXI.0000000000000883 (WP1-WP6)

Muñiz‑Castrillo S, Joubert B, and al. Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features. J Neurol Neurosurg Psychiatry. 2020; 0:1–9. doi.org/10.1136/jnnp-2020-323226 (WP3)

 

Muñiz‑Castrillo S, Vogrig A, Joubert B, and al. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies. Cerebellum. 2020; 19 715-721. https://doi.org/10.1007/s12311-020-01159-x (WP1)

 

Vogrig A, Muñiz‑Castrillo S, Joubert B, and al. Central nervous system complications associated with immune checkpoint inhibitors. J Neurol Neurosurg Psychiatry. 2020; . doi: 10.1136/jnnp-2020-323212 (WP1)

 

Simard C, Vogrig A, Joubert B, and al. Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol Neuroimmunol Neuroinflamm. 2020; 7:e699. DOI: https://doi.org/10.1212/NXI.0000000000000699 (WP1)

 

Déchelotte B, Muñiz‑Castrillo S, Joubert B, and al. Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurological syndromes. Neurol Neuroimmunol Neuroinflamm. 2020; 7(3):e701. https://doi.org/10.1212/NXI.0000000000000701 (WP2)

 

Muñiz‑Castrillo S, Ambati A, Dubois V, and al. Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies. J Neurol. 2020; 267:1906-1911. http://dx.doi.org/10.1007/s00415-020-09782-8 (WP3)

 

Vogrig. A, Gigli, G.L., Segatti, S. and al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020; 267: 26-35http://dx.doi.org/10.1007/s00415-019-09544-1 (WP1)

 

Joubert, B., Belbezier, A., Haesebaert, J. and al. Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies. J Neurology. 2020. https://doi.org/10.1007/s00415-020-09807-2 (WP1)

 

 

Reviews

Marini A, Bernardini A, and al. Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic ReviewNeurlogy 2021. DOI: https://doi.org/10.1212/WNL.0000000000011795 (WP1)

 

Mitoma H, Honnorat J and al. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias. Int. J. Mol. Sci. 2020, 21, 4936. https://doi:10.3390/ijms21144936 (WP1)

 

Muñiz-Castrillo S, and al. Diagnostic des encéphalites auto-immunes. Pratique Neurologique – FMC 2020. doi.org/10.1016/j.praneu.2020.08.006 (WP1) 

 

Vogrig A, Muñiz‑Castrillo S, Desestret V. Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors. Ther Adv Neurol Disord. 2020; 13:1-15https://doi.org/10.1177/1756286420932797 (WP1)

  

Yshii L, Bost C, Liblau R. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications. Frontiers in immunology. 2020; 11:911 https://doi.org/10.3389/fimmu.2020.00991 (WP5)

 

Muñiz‑Castrillo S, Vogrig A, Honnorat J. Associations between HLA and autoimmune neurological diseases with autoantibodies. Autoimmun Highlights. 2020; 11:2. https://doi.org/10.1186/s13317-019-0124-6 (WP3)

 

 

Letters

Mongay-Ochoa N, Vogrig A, Muñiz‑Castrillo S, Honnorat J. Anti‑Hu‑associated paraneoplastic syndromes triggered by immune‑checkpoint inhibitor treatment. J Neurol. 2020https://doi.org/10.1007/s00415-020-09940-y (WP1)

 

Vogrig A, Muñiz‑Castrillo S, Honnorat J. Value of onconeural antibodies in checkpoint inhibitor-related toxicities. Ann Neurol. 2020. https://doi.org/10.1002/ana.25764 (WP1)

 

 

Others

Quero K, Joubert B, et al. Paraneoplastic cerebellar degeneration associated with Hodgkin Lymphoma: A french retrospective cohort. Abstract EP1140. 25th congress of European Hematology Association (EHA). 2020